Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives

Epithelial ovarian cancer (EOC) is the most lethal gynecologic cancer. The gold standard therapeutic approach is a combination of surgery plus chemotherapy. Unfortunately, 80% of patients with EOC suffer recurrence within 2-years and the overall response rate for platinum-resistant epithelial ovaria...

Descripción completa

Detalles Bibliográficos
Autores principales: Awada, Ahmad, Ahmad, Sarfraz, McKenzie, Nathalie D, Holloway, Robert W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379118/
https://www.ncbi.nlm.nih.gov/pubmed/35982728
http://dx.doi.org/10.2147/OTT.S335936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379118/
https://www.ncbi.nlm.nih.gov/pubmed/35982728
http://dx.doi.org/10.2147/OTT.S335936

Ejemplares similares